1,755 filings
Page 24 of 88
6-K
x6mdl33e2cqhtzz
25 Nov 15
Teva and Heptares Enter Agreement to Discover and Develop Novel, Small-Molecule CGRP Antagonists for Treatment of Migraine
12:00am
6-K
wmcodrj bvw
19 Nov 15
Live Filing
12:00am
6-K
95x j142twpvfk
19 Nov 15
Live Filing
12:00am
6-K
rmi5cq
18 Nov 15
Term Loan Credit Agreement
12:00am
6-K
poocut9
17 Nov 15
Teva to Present at the Jefferies Autumn 2015 Global Healthcare Conference
12:00am
6-K
kdszbkbg 6racwx8xsqt
9 Nov 15
Live Filing
12:00am
6-K
6kzc03u6se0vj7bk dc
5 Nov 15
Amendment to Memorandum of Association
12:00am
6-K
4ftgfsd6zk6a5
4 Nov 15
Teva to Present New Respiratory Data at the 2015 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology
12:00am
6-K
a43q9uv zt0e1
29 Oct 15
Teva Reports Third Quarter 2015 Results
12:00am
6-K
sv9wprp1akiojpgl1w
29 Oct 15
Current report (foreign)
12:00am
6-K
4ktfdc2gb5
15 Oct 15
Live Filing
12:00am
6-K
3o809mo
13 Oct 15
Teva Announces Exclusive Launch of Generic Avodart® Capsules In the United States
12:00am
6-K
vab vjfspec
8 Oct 15
Live Filing
12:00am
6-K
vzalk1k
6 Oct 15
Live Filing
12:00am
6-K
u49 iwtdz
1 Oct 15
Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market
12:00am
6-K
c14upw56de 0ap6v
1 Oct 15
Current report (foreign)
12:00am
6-K
okk3jm3l6sxmd34w6ud
30 Sep 15
IMPORTANT NEW DATA FROM TEVA’S TEV-48125 PHASE 2b MIGRAINE PROGRAM PUBLISHED INLANCET NEUROLOGYIN BACK-TO-BACK ARTICLES
12:00am
6-K
ref99jm
29 Sep 15
Bridge Loan Credit Agreement
12:00am
6-K
j3fbtqn
28 Sep 15
Teva Announces Approval of COPAXONE® in Japan for the Prevention of Relapse of Multiple Sclerosis
12:00am
6-K
9glehooyg nq
28 Sep 15
Teva Presents New Reslizumab Data at European Respiratory Society (ERS) International Congress 2015
12:00am